Hematology

Engineered platelets controlled bleeding in mice and pig models of trauma.

Genetically modified stem cells show promise in a targeted approach to taming inflammation in autoimmune diseases.

While vital for a healthy pregnancy, the placenta is not well understood. Researchers now take advantage of spatial biology approaches to plumb its secrets.

Researchers revealed a connection between age-related Y chromosome gene loss and increased heart scarring in men.

Researchers harvest stem cells from patients who have recently had a heart attack and use them to trigger regeneration of their cardiac muscle.

Young blood rejuvenates aging organs in rodents. Researchers are studying the potential to use young blood-based treatments in aging humans too.

New potential drug candidates made entirely of synthetic DNA may outperform current available blood clot treatments and avoid the adverse effects. 

As an alternative to daily pills, a new RNAi drug could lower blood pressure with a twice-yearly injection.

An off-the-cuff request at the local butcher led to a serendipitous discovery about heart valve disease, leading to potential new sex-specific ways to treat it.

Doctors are recording a wave of wins using cord blood to heal sick children. The clinical evidence suggests that more wins may come.

A drug class that blocks a neuronal receptor’s activity could help stroke patients quickly regain their senses of touch and control over movements.

By removing immunosuppressive factors from the blood, researchers hope to give the immune system a fighting chance against advanced tumors.

Scientists developed an alternative to bone marrow transplantation by using technology similar to that of the COVID-19 mRNA vaccines.

For decades, treatment options for sickle cell disease have been extremely limited. Soon, gene therapies and a host of pharmaceuticals could alleviate the immense burden of this disease.

Currently, the only cure for alpha thalassemia is a bone marrow transplant, but the success of gene therapies for related conditions points to a potential new cure.

Inhibitors that target gut microbial enzymes are likely the key to treating a variety of cardiovascular diseases, some of which have no other cure.

A coordinated effort between the stroma, the immune system, and the skin microbiome restores damaged skin.

As an alternative to reconstructive surgery, a degradable implant may offer a new way for the body to reconstruct a breast after mastectomy.

To dismantle healthcare barriers in low-resource areas, researchers measure the color signatures of jaundice and anemia using a device that’s in everyone’s pocket.

Using a zebrafish model, researchers developed a method for producing blood stem cells anywhere in the body with the goal of eventually eliminating the need for bone marrow donors.